HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

Unilever Acquires 82% Of Kalina

You may also be interested in...



With Kalina Acquisition, Unilever Becomes Skin-Care Leader In Russia

Unilever’s acquisition of Ekaterinburg, Russia-based Concern Kalina will bolster the firm’s personal-care positioning in Russia, making it one of the market leaders in a locale where it previously struggled.

With Kalina Acquisition, Unilever Becomes Skin-Care Leader In Russia

Unilever’s acquisition of Ekaterinburg, Russia-based Concern Kalina will bolster the firm’s personal-care positioning in Russia, making it one of the market leaders in a locale where it previously struggled.

FDA Science Board Recommends Larger Nanotech Program Budget

FDA Science Board members say the $7.3 million the agency requested for its first dedicated budget for nanotechnology is not enough

UsernamePublicRestriction

Register

RS017803

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel